Human Genome Epidemiology Literature Finder
|
Records 1 - 9 (of 9 Records) |
| Query Trace: Head and Neck Neoplasms and PIK3CA[original query] |
|---|
| Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers. Proceedings of the National Academy of Sciences of the United States of America 2011 Nov 108 (47): 19024-9. Morris Luc G T, Taylor Barry S, Bivona Trever G, Gong Yongxing, Eng Stephanie, Brennan Cameron W, Kaufman Andrew, Kastenhuber Edward R, Banuchi Victoria E, Singh Bhuvanesh, Heguy Adriana, Viale Agnes, Mellinghoff Ingo K, Huse Jason, Ganly Ian, Chan Timothy |
| A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer. Cancer 2013 May 119 (10): 1823-31. Fury Matthew G, Sherman Eric, Ho Alan L, Xiao Han, Tsai Frank, Nwankwo Oby, Sima Camelia, Heguy Adrian, Katabi Nora, Haque Sofia, Pfister David |
| PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Jun 21 (11): 2530-7. de la Rochefordiere Anne, Kamal Maud, Floquet Anne, Thomas Laurence, Petrow Peter, Petit Thierry, Pop Marius, Fabbro Michel, Kerr Christine, Joly Florence, Sevin Emmanuel, Maillard Sophie, Curé Hervé, Weber Béatrice, Brunaud Claire, Minsat Mathieu, Gonzague Laurence, Berton-Rigaud Dominique, Aumont Maud, Gladieff Laurence, Peignaux Karine, Bernard Virginie, Leroy Quentin, Bieche Ivan, Margogne Audrey, Nadan AnaTereza, Fourchotte Virginie, Diallo Alhassane, Asselain Benard, Plancher Corine, Armanet Sébastien, Beuzeboc Philippe, Scholl Suzy |
| Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival. Cancers of the head & neck 2019 4 5. Mundi Neil, Prokopec Stephenie D, Ghasemi Farhad, Warner Andrew, Patel Krupal, MacNeil Danielle, Howlett Christopher, Stecho William, Plantinga Paul, Pinto Nicole, Ruicci Kara M, Khan Mohammed Imran, Han Myung Woul, Yoo John, Fung Kevin, Sahovaler Axel, Palma David A, Winquist Eric, Mymryk Joe S, Barrett John W, Boutros Paul C, Nichols Anthony |
| NSAID therapy for PIK3CA-Altered colorectal, breast, and head and neck cancer. Advances in biological regulation 2019 Sep 100653. Cai Yi, Yousef Andrew, Grandis Jennifer R, Johnson Daniel |
| Worldwide prevalence of PI3K-AKT-mTOR pathway mutations in head and neck cancer: A systematic review and meta-analysis. Critical reviews in oncology/hematology 2021 Mar 160 103284. Moura Adriana Castelo de, Assad Daniele Xavier, Amorim Dos Santos Juliana, Porto de Toledo Isabela, Barra Gustavo Barcelos, Castilho Rogerio Moraes, Squarize Cristiane Helena, Guerra Eliete Neves Sil |
| Comprehensive Genome profile testing in head and neck cancer. Auris, nasus, larynx 2023 5 . Masashi Kuroki, Ryota Iinuma, Hiroshi Okuda, Kosuke Terazawa, Hirofumi Shibata, Ken-Ichi Mori, Toshimitsu Ohashi, Akitaka Makiyama, Manabu Futamura, Tatsuhiko Miyazaki, Yukio Horikawa, Takenori Oga |
| A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma---A systematic review. Mutation research. Reviews in mutation research 2023 11 108477. Xiaomin Huang, Paul Leo, Lee Jones, Pascal Hg Duijf, Gunter Hartel, Lizbeth Kenny, Sarju Vasani, Chamindie Punyadee |
| Prevalence and effect of PIK3CA H1047R somatic mutation among Indian head and neck cancer patients. Saudi journal of biological sciences 2024 6 31 (8): 104029. Arjita Ghosh, Anbalagan Moort |
- Page last reviewed:Feb 1, 2024
- Content source: